Awards

Titled Professor - 2024

James A. Madura Scholar in the Department of Surgery

About Troy Markel

Troy Markel, MD is the James A. Madura Professor and Vice Chair of the Department of Surgery at Indiana University School of Medicine. He is originally from Hanover, Pennsylvania, where he graduated from Southwestern High School in 1996. He went to the University of Delaware where he obtained his Bachelor of Arts degree in Biology. He then went on to Penn State University College of Medicine for his medical degree, followed by Indiana University for general surgery residency and pediatric surgery fellowship. In 2013, he joined the pediatric surgery faculty at Riley Hospital for Children, where he provides surgical care to infants and children of all ages.

Troy maintains an active basic and translational sciences lab that focuses on novel therapies for the treatment of necrotizing enterocolitis (NEC), a terrible disease that affects the intestines of premature newborns. The disease affects nearly 10% of extremely preterm infants, often requires surgical resection of diseased intestines, and has a mortality rate of 50%. Troy has focused on stem cell therapy for the treatment of NEC and its long term intestinal and neurodevelopmental sequelae. He has partnered with Purdue University to develop a piglet model of NEC and works closely with Ossium Health in Indianapolis and Cynata Therapeutics in Australia to provide clinical grade stem cells for his studies. He has been funded by the NIH, the American College of Surgeons, the Gerber Foundation, and the Thrasher Foundation for his work.

Troy serves as the Vice Chair for Clinical Research for the Riley Institute for Child Health Research. He also sits on the Scientific Advisory Board of the NEC Society, the world’s leading non-profit organization that is dedicated to “Building a World Without NEC”. As such, he has helped to shape research initiatives and policy surrounding NEC and the use of human milk products and probiotics in NICU’s across the country.